Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
39
datasets available to search
ShareScore release 0.7.1
Dataset results
39 results for “cellulitis”
Antibiotic Prescribing Adherence in Treatment of Uncomplicated Cellulitis
<p><strong>Authors:</strong></p><p><strong>* Talha Rizwan, Adnan Khan</strong></p><p>Our Lady's Hospital Navan, Republic of Ireland</p><p><strong>*Corresponding Author</strong>:* Talha Rizwan, Our Lady's Hospital Navan, Republic of Ireland</p>
High-dose vs. Standard-dose Cephalexin for Cellulitis
ClinicalTrials.gov study NCT04471246. IPD Sharing: NO. Countries: 1. Publications: 15.
Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
ClinicalTrials.gov study NCT01671423. IPD Sharing: NO. Countries: 1. Publications: 5.
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
ClinicalTrials.gov study NCT01029782. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
ClinicalTrials.gov study NCT00676130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Adjunctive clindamycin for cellulitis: clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
Objective: To compare flucloxacillin with clindamycin to flucloxacillin alone for the treatment of limb cellulitis. Design: Parallel, double-blinded, randomised controlled trial. Setting: Emergency department attendances and general practice referrals within 20 hospitals in England. Interventions: Flucloxacillin, at a minimum of 500 mg 4 times per day for 5 days, with clindamycin 300 mg 4 times per day for 2 days given orally versus flucloxacillin given alone. Main outcome measures: The primary outcome was improvement at day 5. This was defined as being afebrile with either a reduction in affected skin surface temperature or a reduction in the circumference of the affected area. Secondary outcomes included resolution of systemic features, resolution of inflammatory markers, recovery of renal function, reduction in the affected area, decrease in pain, return to work or normal activities and the absence of increased side effects. Results: 410 patients were included in the trial. No significant difference was seen in improvement at day 5 for flucloxacillin with clindamycin (136/156, 87%) versus flucloxacillin alone (140/172, 81%)—OR 1.55 (95% CI 0.81 to 3.01), p=0.174. There was a significant difference in the number of patients with diarrhoea at day 5 in the flucloxacillin with clindamycin allocation (34/160, 22%) versus flucloxacillin alone (16/176, 9%)—OR 2.7 (95% CI 1.41 to 5.07), p=0.002. There was no clinically significant difference in any secondary outcome measures. There was no significant difference in the number of patients stating that they had returned to normal activities at the day 30 interview in the flucloxacillin with clindamycin allocation (99/121, 82%) versus flucloxacillin alone (104/129, 81%)—adjusted OR 0.90 (95% CI 0.44 to 1.84). Conclusions: The addition of a short course of clindamycin to flucloxacillin early on in limb cellulitis does not improve outcome. The addition of clindamycin doubles the likelihood of diarrhoea within the first few days.
Duration of ANtibiotic Therapy for CEllulitis
ClinicalTrials.gov study NCT02032654. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis
ClinicalTrials.gov study NCT02715037. IPD Sharing: NO. Countries: 1. Publications: 4.
Use of Corticosteroids in Children With Cellulitis
ClinicalTrials.gov study NCT02087527. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
ClinicalTrials.gov study NCT04456556. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis
ClinicalTrials.gov study NCT02230813. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
ClinicalTrials.gov study NCT00295178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy
ClinicalTrials.gov study NCT03917134. IPD Sharing: YES. Countries: 1. Publications: 34.
A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis
ClinicalTrials.gov study NCT01795092. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adjunctive Clindamycin for Cellulitis: C4C Trial.
ClinicalTrials.gov study NCT01876628. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
ClinicalTrials.gov study NCT01706913. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Penicillin for the Emergency Department Outpatient Treatment of CELLulitis
ClinicalTrials.gov study NCT02922686. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis
ClinicalTrials.gov study NCT07345819. IPD Sharing: NO. Countries: 1. Publications: 3.
Data from: Adjunctive clindamycin for cellulitis: clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
Open the record for dataset details and reuse information.
The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
ClinicalTrials.gov study NCT05023200. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.